http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0140255-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23ddf853ccbba5818f564285808e5e08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82584544ee1a1aa902bcc487d871bc81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57407d268098218761834c98221025d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e7e69e3bae914a4270e4b24707c7ff4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-004
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-26
filingDate 2000-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0b523b71c2824df984dbc339172902d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6a5a322fd6bbf296addf294e201b727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_154dadd2acf4c7a9433d60fe5d6da650
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b8779560bcdc894dbff65bfacfadc6b
publicationDate 2001-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0140255-A3
titleOfInvention 14,15-beta-methylene substituted androgens
abstract The disclosed invention relates to the unexpected finding of novel steroids which are characterized by a 14β,15β-cyclopropane ring and a 17α hydroxymethyl group. These steroids according to the invention are found to have in common an androgenic activity. They can be used for the preparation of an agent for male contraception, as well as for the preparation of a medicament for the treatment of androgen insufficiency.
priorityDate 1999-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0768316-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0277676-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0053619-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3086027-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9967276-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397482

Total number of triples: 32.